USE OF CD137 ANTAGONISTS FOR THE TREATMENT OF TUMORS

Details for Australian Patent Application No. 2003290059 (hide)

Owner SCHWARZ, Herbert

Inventors SCHWARZ, Herbert; WITTMANN, Margarethe

Pub. Number AU-A-2003290059

PCT Number PCT/EP2003/0143

PCT Pub. Number WO2004/055513

Priority 02028264.6 16.12.02 EP

Filing date 16 December 2003

Wipo publication date 9 July 2004

International Classifications

G01N 033/48 Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

8 April 2004 Complete Application Filed

  Priority application(s): 02028264.6 16.12.02 EP

19 August 2004 Application Open to Public Inspection

  Published as AU-A-2003290059

1 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003290060-FORMULATION COMPRISING FENOFIBRIC ACID, A PHYSIOLOGICALLY ACCEPTABLE SALT OR DERIVATIVE THEREOF

2003290058-PYROGENIC SILICON DIOXIDE AND A DISPERSION THEREOF